17 research outputs found
FDG Dose Extravasations in PET/CT: Frequency and Impact on SUV Measurements
Objectives: Positron emission tomography (PET)/CT with 18F-FDG has proven to be effective in detecting and assessing various types of cancers. However, due to cancer and/or its therapy, intravenous (IV) FDG injection may be problematic resulting in dose extravasations. In the most frequently used field of view (FOV), arms-up, and base of skull to upper thigh [limited whole body (LWB)], the injection site may not be routinely imaged. The purpose of this study was to evaluate the frequency of dose extravasations in FDG PET and the potential impact on standard uptake value (SUV) measurements. Methods: True whole body FDG PET/CT scans (including all extremities) of 400 patients were retrospectively reviewed. A log recorded cases of IV dose extravasations. When possible, SUVs were measured in two frequently used reference locations: mediastinum and liver. The SUVs were obtained in the same patients who had studies with and without FDG extravasations within an average of 3 months without interval therapy. Results: Of the 400 scans, 42 (10.5%) had extravasations on the maximum intensity projections images. In scans with or without dose infiltration, FDG injection site was at or distal to the antecubital fossa in 97% of studies. Of those 42 cases, dose infiltration was within the LWB FOV in 29/42 (69%) and outside in the remaining 13/42 (31%). Of those 42 patients, 5 had repeat PET studies with no interval therapy. For those 5 patients, liver maximum SUV was 11.7% less in patients with infiltration than those without (2.22 ± 0.54 vs. 2.48 ± 0.6). Mediastinum SUVmax was 9.3% less in patients with infiltration than those without (1.72 ± 0.54 vs. 1.88 ± 0.49). Conclusion: We conclude dose extravasations were commonly encountered (10.5%) in PET/CT. However, it is underreported by at least 31% due to omitting injection site from the FOV. When present, extravasations may lead to underestimation of SUVmax. Therefore, it should not only be avoided but also reported in order to avoid false interpretations of the exam
Extração de oleuropeína a partir de folhas de oliveira utilizando solvente hidroalcoólico
Cochlear Implantation in Extraordinary Cases
Background: Although cochlear implantation has been almost a standard
otological procedure worldwide, it may still create a dilemma for the
surgeon in some unusual instances such as Seckel syndrome, aural atresia
and posterior fossa arachnoid cyst.
Case Report: Three extraordinary cases of cochlear implantation were
reported. The first case was a case of Seckel syndrome with a cardiac
pacemaker due to complete atrioventricular block. The second case had
posterior fossa arachnoid cyst that had retrosigmoid cyst removal and
cochlear implantation simultaneously. The last case had cochlear
implantation in the ear with congenital aural atresia. All cases could
be implanted successfully with full electrode insertion and good
audiological outcome. Delayed facial paralysis that occurred in the
patient with arachnoid cyst resolved spontaneously.
Conclusion: This study addressed the efficiency of cochlear implantation
in cases of Seckel syndrome, complete atrioventricular block managed
with cardiac pacemaker, congenital aural atresia and posterior fossa
arachnoid cyst. In addition, the retrosigmoid approach and cochlear
implantation can be performed simultaneously
Recommended from our members
Impact of PET/CT on initial staging, restaging and treatment management of anal cancer: a clinical case with literature review
Distant extrapelvic metastases appear in approximately in 10% of the patients with squamous cell anal cancer (SCAC) and survival depends on the treatment strategy. Exact staging leads to optimal planning of multimodality therapy and the adequate evaluation of treatment response can improve the prognosis of the disease. Diagnosis and staging of SCAC are commonly performed using contrast-enhanced computerized tomography(CT) and interpretation of the findings for tumor biological behavior. F18-fluoro-2 deoxy-D glucose positron emission tomography((18)F-FDG PET) reveals aspects of tumor function and allows metabolic measurements. Combined PET/CT scans permit exact localization with anatomical criteria of the hypermetabolic (18)F-FDG avid malignant lesions. We present a patient with SCAC in whom, according to PET/CT findings, the initial stage was changed from II (T2N0M0) to III A (T2N2M0). Radiation therapy (RT) and chemotherapy achieved a good therapeutic response but early follow up revealed new paraaortic lymph node (LN) metastases, as well as an uncommon left supraclavicular LN metastasis from the same primary carcinoma. The disease was restaged as stage IV (T2N2M1) and radiation therapy was substituted by chemotherapy
Recommended from our members
Scintigraphic visualization of an epigastric sentinel node in recurrent breast cancer after lumpectomy and postoperative radiation therapy
Sentinel node imaging and biopsy have become standard procedures for staging early breast cancer. Positive sentinel lymph node (SLN) biopsy necessitates the need for axillary lymph node dissection (ALND). Failure to visualize a sentinel lymph node in recurrent breast cancer after treatment by surgery, chemotherapy, and high-dose postoperative radiation therapy is almost the case in every patient. The reason for failure to visualize the sentinel node is the fibrosis that follows high-dose radiotherapy and blocks the lymphatics preventing spread of the tumor cells to the lymph nodes. Alternative pathways for the drainage of lymph from the breast are developed in these patients. We have previously reported on the alternative pathways of lymphatics to the contralateral axilla, supraclavicular area, and also reported on the development of intramammary lymph nodes. In this report, we are presenting another alternative pathway of lymphatics to the region of the epigastrium below the lower end of the sternum
Management of children with auditory neuropathy spectrum disorder (ANSD)
ABSTRACT INTRODUCTION: ANSD is a challenging problem. OBJECTIVE: To present our experience on management of the children with ANSD with respect to clinical data. METHODS: This retrospective study included all children younger than 16 years of age who applied to the department between 2005 and 2013 (with the exception of newborn hearing screening NHS referrals). The data were derived from pure tone, OAEs and ABR tests, and further medical risk factors of the subjects were evaluated. RESULTS: ANSD was recognized in 74 ears of 40 children (B/U: 34/6) among 1952 children with SNHL (2.04%) detected among 9520 applicants to the department (0.42%). The clinical tests revealed that hearing loss greater than 15 dB was present in both ears of 38 cases. The degree of hearing loss was profound in 48% children, severe in 12% children, moderate in 28% children, mild in 10% children and normal in 5% children. ABRs were absent/abnormal in 37/3 ears and CMs were detected in all. Acoustic reflexes were absent in all ears. Rehabilitation was managed by CI and hearing aids in 15 and 23 cases, respectively. FM system was given to two cases displaying normal hearing but poor speech discrimination in noisy environments. CONCLUSION: ANSD is a relatively challenging problem for the audiology departments because of its various clinical features and difficulties in management. Our patients with ANSD most commonly displayed profound hearing loss. The number of overlooked cases may be minimized by performing ABR and OAE in every case referred with the suspicion of hearing loss
458 PROSPECTIVE RANDOMIZED TRIAL COMPARING PERCUTANEOUS NEPHROLITHOTOMY, SHOCK WAVE LITHOTRIPSY AND OBSERVATION FOR ASYMPTOMATIC LOWER POLE CALCULI: INITIAL RESULTS
Recommended from our members
Impact of PET/CT in comparison with same day contrast enhanced CT in breast cancer management
PURPOSETo evaluate the impact of F-18 fluorodeoxyglucose (FDG) positron emission tomography with fused computerized tomography (PET/CT) in comparison with same day contrast enhanced CT (CE-CT) in breast cancer management.METHODSeventy studies in 49 breast cancer patients, 17 for initial and 53 for restaging disease were included. All patients underwent PET/CT for diagnostic purposes followed by CE-CT scans of selected body regions. PET/CT was started approximately 90 minutes following IV injection of 10-15 mCi of F-18 FDG on a GE Discovery PET/CT system. Oral contrast was given before F-18 FDG injection. The CE-CT was performed according to departmental protocol.RESULTSOut of a total of 257 lesions, 210 were concordant between PET/CT and CE-CT. There were 47 discordant lesions, which were verified by either biopsy (35) or follow-up (12 PET positive CE-CT negative lesions). PET/CT correctly identified 25 true positive (TP). CE-CT identified 2 TP lesions missed by PET/CT which were false negatives (FNs): one liver metastasis with necrosis, which was nonavid to FDG uptake because of necrosis and a second one missed on abdominal metastatic node, which did not change staging or treatment. PET/CT incorrectly identified 2 false positive lesions while CE-CT incorrectly identified 18 false positive. TP recurrence of the disease was found by PET/CT in 44% (15/34 pts), whereas 56% (19/34 pts) were free of disease. The CE-CT described progression of the disease in 1 true negative PET/CT study and no progression in 2 TP PET/CT studies. The sensitivity, specificity, accuracy, positive productive value, and negative productive value for PET/CT were 97.8%, 93.5%, 97.3%, 99.1%, 85% and for CE-CT were 87.6%, 42%, 82.1%, 91.6%, 31.7%.CONCLUSIONIn this study, PET/CT played a more important role than CE-CT scans alone and provided an impact on the management of breast cancer patients
Management of children with auditory neuropathy spectrum disorder (ANSD)
Introduction: ANSD is a challenging problem.
Objective: To present our experience on management of the children with
ANSD with respect to clinical data.
Methods: This retrospective study included all children younger than 16
years of age who applied to the department between 2005 and 2013 (with
the exception of newborn hearing screening NHS referrals). The data were
derived from pure tone, OAEs and ABR tests, and further medical risk
factors of the subjects were evaluated.
Results: ANSD was recognized in 74 ears of 40 children (B/U: 34/6) among
1952 children with SNHL (2.04\%) detected among 9520 applicants to the
department (0.42\%). The clinical tests revealed that hearing loss
greater than 15 dB was present in both ears of 38 cases. The degree of
hearing loss was profound in 48\% children, severe in 12\% children,
moderate in 28\% children, mild in 10\% children and normal in 5\%
children. ABRs were absent/abnormal in 37/3 ears and CMs were detected
in all. Acoustic reflexes were absent in all ears. Rehabilitation was
managed by CI and hearing aids in 15 and 23 cases, respectively. FM
system was given to two cases displaying normal hearing but poor speech
discrimination in noisy environments.
Conclusion: ANSD is a relatively challenging problem for the audiology
departments because of its various clinical features and difficulties in
management. Our patients with ANSD most commonly displayed profound
hearing loss. The number of overlooked cases may be minimized by
performing ABR and OAE in every case referred with the suspicion of
hearing loss. (C) 2015 Associacao Brasileira de Otorrinolaringologia e
Cirurgia Cervico-Facial. Published by Elsevier Editora Ltda. This is an
open access article under the CC BY license
(http://creativecornmons.org/licenses/by/4.0/)